Patent · US Active

Treatment of intrahepatic cholestatic diseases

US11224580B2 · kind B2 · utility

0Cited by
20References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 18, 2020
Grant dateJan 18, 2022
Priority date—
Expiry dateSep 18, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P1/16
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Treatment of intrahepatic cholestatic diseases by therapy with seladelpar or a salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.